Democratization of Medical Publishing Crucial During COVID-19 Pandemic

 Breaking News
  • No posts were found

Democratization of Medical Publishing Crucial During COVID-19 Pandemic

November 02
21:45 2020
Democratization of Medical Publishing Crucial During COVID-19 Pandemic
Fastest growing open access journal, Cureus, revolutionizes research and disrupts status quo of medical journal paywalls

SAN FRANCISCO – November 2nd, 2020 – Since the dawn of the medical journal at the beginning of the 18th century, politics, elitism and costs have heavily restricted the publishing of important medical research and clinical observations. The Cureus Journal of Medical Science (pronounced “curious”) was conceived by neurosurgeon and entrepreneur John R. Adler, M.D., with a mission to democratize medical knowledge thereby making it more accessible to physicians, researchers, patients, caregivers and the general public. Cureus is the first and only medical journal to offer a DIY approach to scientific publishing, providing unique step-by-step article templates to speed the publication process while ensuring 100 percent free access for readers. In 2020 Cureus’ submissions tripled relative to last year, partly attributable to the velocity with which important new medical knowledge was being generated around Covid-19. Many of these articles were case reports documenting critical observations from the frontlines of the pandemic.

Cureus believes in the unique value of patient case reports, the observations contained within being necessary first steps for driving all of medical science. Invaluable first-hand experience acquired in the trenches of harried hospitals and clinics, mandates efficient documentation and communication; that is what Cureus case reports enable. “We subscribe to the belief that all credible medical knowledge can and should have an audience,” said Dr. Adler, founder and chief executive officer of Cureus, and editor-in-chief of The Cureus Journal of Medical Science. “Authors trust Cureus for rigorous yet efficient peer-review, and then for us to provide an entire world of readers unimpeded free access to the content within” Cureus aims to publish millions of articles per year. Published articles are discussed and rated by a Cureus audience of more than 3.5 million readers. This is accomplished via the journal’s unique post-publication peer review rating process, Scholarly Impact Quotient, or SIQ™ score. Readers assign their rating to help determine article quality and clinical significance. SIQ™ harnesses the innate “wisdom of the crowd,” including peer reviewers, editors, colleagues, and doctors and researchers, to assess article importance. Cureus is indexed in PubMed, Google Scholar, Web of Science and other indexing services.

About Cureus

The Cureus Journal of Medical Science is a no-cost peer-reviewed online medical publishing platform that leverages a unique crowd-sourced post-publications review process. Relying on the collective intelligence of its clinical community, Cureus enables faster publication, greater access, and ultimately, better research. For more information about publishing and peer reviewing with the Cureus Journal of Medical Science, or to access cutting edge medical research visit www.cureus.com.

Media Contact
Company Name: The Cureus Journal of Medical Science
Contact Person: Henrik Bacho
Email: Send Email
Phone: 415-308-5586
Country: United States
Website: https://www.cureus.com/

Related Articles

Categories